26 jul

12% sales growth at Direct & Institutional

Financial highlights

Net sales
Down 2% to € 647.1 million; growth from acquisitions at Direct & Institutional; sales decrease at Pharmacies Netherlands and Pharmacies Poland.

EBITA from ordinary activities
 Decrease by 18% to € 24.3 million; mainly due to € 5.9 million decrease at Pharmacies Netherlands.

Net result
 Amounted to € 12.3 million, reflecting lower EBITA and higher amortisation of customer relationships.

Net earnings per share from ordinary activities
 Amounted to € 0.29, decrease by 12% reflecting lower EBITA from ordinary activities, partly offset by lower number of shares outstanding.

Outlook 2012
 Further specification of previously given guidance: EBITA between € 111 million and € 116 million. 

Operational highlights

Direct & Institutional

Share
© Publicnow - 2012